Literature DB >> 21957305

Molecular determinants of arenavirus Z protein homo-oligomerization and L polymerase binding.

Maria Eugenia Loureiro1, Maximiliano Wilda, Jesica M Levingston Macleod, Alejandra D'Antuono, Sabrina Foscaldi, Cristina Marino Buslje, Nora Lopez.   

Abstract

The arenavirus Z is a zinc-binding RING protein that has been implicated in multiple functions during the viral life cycle. These roles of Z involve interactions with viral and cellular proteins that remain incompletely understood. In this regard, Z inhibits viral RNA transcription and replication through direct interaction with the viral L polymerase. Here, we defined the L-binding domain of Tacaribe virus (TCRV) Z protein and the structural requirements mediating Z homo-oligomerization. By using site-directed mutagenesis, coimmunoprecipitation, and functional assays, we showed that residues R37, N39, W44, L50, and Y57, located around the zinc coordination site I, play a critical role in the Z-L interaction. We also found that Z protein from either TCRV or the pathogenic Junin virus (JUNV) self-associates into oligomeric forms in mammalian cells. Importantly, mutation of the myristoylation site, the strictly conserved residue G at position 2, severely impaired the ability of both TCRV Z and JUNV Z to self-interact as well as their capacity to accumulate at the plasma membrane, strongly suggesting that Z homo-oligomerization is associated with its myristoylation and cell membrane targeting. In contrast, disruption of the RING structure or substitution of W44 or N39, which are critical for L protein recognition, did not affect Z self-binding. Overall, the data presented here indicate that homo-oligomerization is not a requirement for Z-L interaction or Z-mediated polymerase activity inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957305      PMCID: PMC3209362          DOI: 10.1128/JVI.05691-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Membrane association induces a conformational change in the Ebola virus matrix protein.

Authors:  S Scianimanico; G Schoehn; J Timmins; R H Ruigrok; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

3.  Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis.

Authors:  Tatjana I Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

5.  The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control.

Authors:  Z Topcu; D L Mack; R A Hromas; K L Borden
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

6.  The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.

Authors:  E J Campbell Dwyer; H Lai; R C MacDonald; M S Salvato; K L Borden
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected].

Authors:  Thomas Strecker; Robert Eichler; Jan ter Meulen; Winfried Weissenhorn; Hans Dieter Klenk; Wolfgang Garten; Oliver Lenz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes.

Authors:  N López; R Jácamo; M T Franze-Fernández
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.

Authors:  A Kentsis; E C Dwyer; J M Perez; M Sharma; A Chen; Z Q Pan; K L Borden
Journal:  J Mol Biol       Date:  2001-09-28       Impact factor: 5.469

10.  Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis.

Authors:  Rodrigo Jácamo; Nora López; Maximiliano Wilda; María T Franze-Fernández
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more
  24 in total

1.  Architecture and regulation of negative-strand viral enzymatic machinery.

Authors:  Philip J Kranzusch; Sean P J Whelan
Journal:  RNA Biol       Date:  2012-07-01       Impact factor: 4.652

2.  The use of novel epitope-tagged arenaviruses reveals that Rab5c-positive endosomal membranes are targeted by the LCMV matrix protein.

Authors:  Christopher M Ziegler; Emily A Bruce; Jamie A Kelly; Benjamin R King; Jason W Botten
Journal:  J Gen Virol       Date:  2018-02       Impact factor: 3.891

3.  Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus.

Authors:  Mohammad Uzzal Hossain; Taimur Md Omar; Arafat Rahman Oany; K M Kaderi Kibria; Abu Zaffar Shibly; Md Moniruzzaman; Syed Raju Ali; Md Monirul Islam
Journal:  3 Biotech       Date:  2018-01-16       Impact factor: 2.406

4.  Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.

Authors:  Marco A Goicochea; Juan C Zapata; Joseph Bryant; Harry Davis; Maria S Salvato; Igor S Lukashevich
Journal:  Vaccine       Date:  2012-01-09       Impact factor: 3.641

Review 5.  Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.

Authors:  Lisa McLay; Aftab Ansari; Yuying Liang; Hinh Ly
Journal:  Antiviral Res       Date:  2012-12-20       Impact factor: 5.970

Review 6.  Arenavirus budding: a common pathway with mechanistic differences.

Authors:  Svenja Wolff; Hideki Ebihara; Allison Groseth
Journal:  Viruses       Date:  2013-01-31       Impact factor: 5.048

7.  Cryo-EM structures of Lassa and Machupo virus polymerases complexed with cognate regulatory Z proteins identify targets for antivirals.

Authors:  Xin Xu; Ruchao Peng; Qi Peng; Min Wang; Ying Xu; Sheng Liu; Xiaolin Tian; Haiteng Deng; Yimin Tong; Xiaoyou Hu; Jin Zhong; Peiyi Wang; Jianxun Qi; George F Gao; Yi Shi
Journal:  Nat Microbiol       Date:  2021-06-14       Impact factor: 17.745

Review 8.  Uncovering viral protein-protein interactions and their role in arenavirus life cycle.

Authors:  Maria Eugenia Loureiro; Alejandra D'Antuono; Jesica M Levingston Macleod; Nora López
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

Review 9.  Advanced vaccine candidates for Lassa fever.

Authors:  Igor S Lukashevich
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

Review 10.  Multifunctional nature of the arenavirus RING finger protein Z.

Authors:  Sarah Katharina Fehling; Frank Lennartz; Thomas Strecker
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.